Being gold and also being samples (not core), I would not expect any report of visuals.
(Apart from that though, I think that the ASX frowns upon reporting visuals anyway.)
I therefore think that we won't see any reports until a reasonable number of assays have been received.
It is possible. therefore. that we could see the updated Scoping Study before SE assays. It should give the price a boost.
"We are also anticipating the imminent delivery of the Revised Scoping Study, which, given the current gold prices, is evaluating both toll treatment and owner-operate processing plant scenario"
SPQ Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held
